全民可用的新冠疫苗：这项无专利技术最终可能为全球进行接种。 - Suppr

Suppr

超能文献

A COVID Vaccine for All: This patent-free technology could finally inoculate the world.

作者信息

Bottazzi Maria Elena, Hotez Peter

出版信息

Sci Am. 2022 Mar 1;326(3):10. doi: 10.1038/scientificamerican0322-10.

DOI:10.1038/scientificamerican0322-10

PMID:39016744

Abstract

摘要

相似文献

A COVID Vaccine for All: This patent-free technology could finally inoculate the world.

Sci Am. 2022 Mar 1;326(3):10. doi: 10.1038/scientificamerican0322-10.

Innovations and development of Covid-19 vaccines: A patent review.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

The patent maze of COVID 19 vaccines.

Expert Opin Ther Pat. 2021 Dec;31(12):1177-1188. doi: 10.1080/13543776.2021.1945581. Epub 2021 Jul 26.

The COVID-19 vaccine patent: a right without rationale.

Med Humanit. 2023 Mar;49(1):128-133. doi: 10.1136/medhum-2022-012386. Epub 2022 May 6.

Pledging Patent Rights for Fighting Against the COVID-19: From the Ethical and Efficiency Perspective.

J Bus Ethics. 2022;179(3):683-696. doi: 10.1007/s10551-021-04873-6. Epub 2021 Jun 17.

Vaccine inequity-induced COVID-19 dilemma: Time to sober up.

Leg Med (Tokyo). 2024 Feb;66:102364. doi: 10.1016/j.legalmed.2023.102364. Epub 2023 Dec 8.

Intellectual Property Rights and Vaccines.

Methods Mol Biol. 2022;2412:505-518. doi: 10.1007/978-1-0716-1892-9_28.

Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.

Hum Vaccin Immunother. 2018;14(10):2497-2502. doi: 10.1080/21645515.2018.1480240. Epub 2018 Jun 29.

Managing the patent thicket and maximizing patent lifetime in vaccine technology.

Hum Vaccin. 2010 Oct;6(10):860-3. doi: 10.4161/hv.6.10.13377. Epub 2010 Oct 1.

A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.

J Formos Med Assoc. 2022 Aug;121(8):1425-1430. doi: 10.1016/j.jfma.2021.10.004. Epub 2021 Oct 28.

引用本文的文献

The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Lancet. 2022 Oct 8;400(10359):1224-1280. doi: 10.1016/S0140-6736(22)01585-9. Epub 2022 Sep 14.

Commentary: University Technology Transfer Has Made a Significant Contribution to Fighting COVID-19 while Ensuring Global Access.

Healthc Policy. 2022 May;17(4):26-36. doi: 10.12927/hcpol.2022.26829.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A COVID Vaccine for All: This patent-free technology could finally inoculate the world.

Sci Am. 2022 Mar 1;326(3):10. doi: 10.1038/scientificamerican0322-10.

Innovations and development of Covid-19 vaccines: A patent review.

J Infect Public Health. 2022 Jan;15(1):123-131. doi: 10.1016/j.jiph.2021.10.021. Epub 2021 Oct 23.

The patent maze of COVID 19 vaccines.

Expert Opin Ther Pat. 2021 Dec;31(12):1177-1188. doi: 10.1080/13543776.2021.1945581. Epub 2021 Jul 26.

The COVID-19 vaccine patent: a right without rationale.

Med Humanit. 2023 Mar;49(1):128-133. doi: 10.1136/medhum-2022-012386. Epub 2022 May 6.

Pledging Patent Rights for Fighting Against the COVID-19: From the Ethical and Efficiency Perspective.

J Bus Ethics. 2022;179(3):683-696. doi: 10.1007/s10551-021-04873-6. Epub 2021 Jun 17.

Vaccine inequity-induced COVID-19 dilemma: Time to sober up.

Leg Med (Tokyo). 2024 Feb;66:102364. doi: 10.1016/j.legalmed.2023.102364. Epub 2023 Dec 8.

Intellectual Property Rights and Vaccines.

Methods Mol Biol. 2022;2412:505-518. doi: 10.1007/978-1-0716-1892-9_28.

Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.

Hum Vaccin Immunother. 2018;14(10):2497-2502. doi: 10.1080/21645515.2018.1480240. Epub 2018 Jun 29.

Managing the patent thicket and maximizing patent lifetime in vaccine technology.

Hum Vaccin. 2010 Oct;6(10):860-3. doi: 10.4161/hv.6.10.13377. Epub 2010 Oct 1.

A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.

J Formos Med Assoc. 2022 Aug;121(8):1425-1430. doi: 10.1016/j.jfma.2021.10.004. Epub 2021 Oct 28.

引用本文的文献

The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Lancet. 2022 Oct 8;400(10359):1224-1280. doi: 10.1016/S0140-6736(22)01585-9. Epub 2022 Sep 14.

Commentary: University Technology Transfer Has Made a Significant Contribution to Fighting COVID-19 while Ensuring Global Access.

Healthc Policy. 2022 May;17(4):26-36. doi: 10.12927/hcpol.2022.26829.